No FDA-approved peptides for inflammation exist as a drug class. See which approved peptides affect inflammation and which popular ones remain unapproved.
The FDA has not approved any peptide specifically to treat inflammation. A small number of approved peptides, including corticotropin injection (Acthar Gel) and glatiramer acetate (Copaxone), can reduce inflammation or modulate the immune system for narrow, labeled conditions, but none of them is a general-purpose anti-inflammatory drug. Most peptides sold online for inflammation, such as BPC-157 and TB-500, are not FDA-approved for human use in the United States.
What "FDA-Approved Peptides for Inflammation" Actually Means
FDA approval is granted to one specific drug, made by one manufacturer, for one specific medical condition. There is no approval that covers "peptides" as a category, and there is no approved peptide whose label simply says "inflammation."
That distinction matters because peptide marketing often blurs it. A seller may point to a legitimately approved peptide, then ship you a different, unapproved compound that regulators have never reviewed for safety, purity, or effectiveness.
Most pages ranking for the best peptides for inflammation are selling unapproved compounds or affiliate links to them. Very few of those pages mention that the FDA has never evaluated the product being promoted.
FDA-Approved Peptides That Affect Inflammation
Each drug below is approved for a specific diagnosis, not for inflammation in general. Some happen to work partly through anti-inflammatory or immune pathways.
| Peptide drug | FDA-approved use | How it relates to inflammation |
|---|---|---|
| Corticotropin injection (Acthar Gel) | MS flares, rheumatoid arthritis, lupus, psoriatic arthritis, infantile spasms | A 39-amino-acid peptide that triggers cortisol release, which suppresses inflammation |
| Glatiramer acetate (Copaxone, Glatopa) | Relapsing forms of multiple sclerosis | Shifts immune activity away from the inflammatory attacks that damage myelin |
| Linaclotide (Linzess) | IBS with constipation, chronic idiopathic constipation | Reduces abdominal pain through a gut receptor, not through systemic anti-inflammation |
| Teduglutide (Gattex) | Short bowel syndrome | Promotes intestinal repair and reduces inflammation in treated gut tissue |
| Semaglutide (Ozempic, Wegovy) | Type 2 diabetes, chronic weight management | Studies link GLP-1 drugs to lower inflammatory markers, but that is not an approved use |
It also helps to remember that inflammation is not a disease. It is a process behind arthritis, colitis, dermatitis, and dozens of other conditions, so any real anti-inflammatory peptide would need separate trials in each one.
Peptides Marketed for Inflammation That Are Not FDA-Approved
It helps to know what peptides are not fda approved before you spend money online. The compounds below are widely sold but have no FDA approval for human use:
- BPC-157 — a synthetic fragment studied mainly in animals, never approved in the US.
- TB-500 (thymosin beta-4 fragment) — sold as a "research chemical" with no approved human indication.
- Thymosin alpha-1 — approved in some countries, not in the United States.
- KPV — an alpha-MSH fragment with no approved human use.
- LL-37 and GHK-Cu — lab and cosmetic ingredients without FDA drug approval.
The bpc-157 peptide for inflammation is the most searched of these, and it is also one the FDA has specifically restricted. In 2023 the agency placed BPC-157 on its category 2 bulk substances list, which blocks compounding pharmacies from legally preparing it.
How to Get Peptides for Inflammation Legally
In practice, how to get peptides for inflammation comes down to two legal routes: a prescription for an FDA-approved product, or enrollment in a registered clinical trial.
- Talk to a physician. A doctor can prescribe an approved peptide if you have a condition it is labeled for, and can discuss off-label options where evidence supports them.
- Use a licensed pharmacy. If you are wondering where to buy fda-approved peptides, the answer is a US pharmacy that requires a prescription — not a website that labels vials "for research use only."
- Look for clinical trials. ClinicalTrials.gov lists studies on investigational anti-inflammatory peptides, and participants receive monitored, regulated product.
- Check the FDA's Orange Book and Purple Book. These databases list exactly which peptide products are approved and what they are approved for.
Compounded peptides are a gray area. A 503A or 503B pharmacy can only compound from permitted bulk ingredients, and most inflammation-related peptides never made that list.
Safety Risks and Red Flags
Unapproved peptides are not automatically dangerous, but they are unregulated. No one has verified the dose, purity, or sterility of what is in the vial.
- Contamination and dosing errors are the most commonly reported problems with gray-market peptides.
- Non-sterile injectables from unverified sources carry a real infection risk.
- Immune-modulating peptides can worsen autoimmune conditions or interact with immunosuppressant drugs.
- Even approved peptides have side effects — Acthar Gel can raise blood sugar and blood pressure, and GLP-1 drugs commonly cause nausea.
Anyone considering a peptide for an inflammatory condition should speak with a healthcare professional first, especially if they already take biologics, steroids, or other immunosuppressive medication.
The Bottom Line
No FDA-approved peptide is marketed specifically for inflammation. Corticotropin injection and glatiramer acetate are the closest approved options, and both are limited to specific diagnoses.
BPC-157, TB-500, KPV, and similar compounds remain unapproved, and the FDA has moved to restrict compounding of some of them. If a website promises an anti-inflammatory peptide without a prescription, treat that as a warning sign rather than a shortcut.
Frequently Asked Questions
Are there any FDA-approved peptides for inflammation?
No peptide is FDA-approved with a general inflammation indication. Corticotropin injection (Acthar Gel) is approved for specific inflammatory and autoimmune conditions such as rheumatoid arthritis, lupus, and MS flares, and glatiramer acetate is approved for relapsing multiple sclerosis. Both are prescription drugs for narrow uses, not general anti-inflammatories.
Is BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human use in the United States, and the FDA has placed it on its category 2 bulk substances list, which prevents compounding pharmacies from legally using it. Products labeled BPC-157 sold online are typically marketed as research chemicals and are not reviewed for safety, purity, or strength.
Can I buy peptides for inflammation over the counter?
No. Every FDA-approved peptide is a prescription product, so nothing legitimate is sold over the counter as an anti-inflammatory peptide. Vials sold without a prescription are unapproved research chemicals, and buyers have no guarantee of dose, sterility, or identity.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.